Conference Coverage

VIDEO: Helping cancer patients cope with psychological side effects


 

AT ASCO 2017

– Oncologists are highly skilled at minimizing side effects associated with toxic but curative therapies, but are less adept at helping patients cope with the distress, anxiety, fear, and other emotions associated with cancer.

Three studies presented at the annual meeting of the American Society of Clinical Oncology detail randomized, controlled trials of psychological interventions aimed at helping patients cope with a new cancer diagnosis, reduce fears of a recurrence, and come to grips with the realities of advanced disease, including fears of death or disability.

Don S. Dizon, MD, from the Massachusetts General Hospital Cancer Center, Boston, discusses the social and financial barriers that cancer patients face when they experience distress, and the difficulties that providers face with limited time and financial resources to help patients cope in this video interview.

Dr. Dizon reported having no relevant disclosures.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Recommended Reading

APF530 for nausea and vomiting prevention following cisplatin: phase 3 MAGIC trial analysis
MDedge Hematology and Oncology
Patterns of care with regard to whole-brain radiotherapy technique and delivery among academic centers in the United States
MDedge Hematology and Oncology
Emergency department use by recently diagnosed cancer patients in California
MDedge Hematology and Oncology
Distress management in cancer patients in Puerto Rico
MDedge Hematology and Oncology
Prevention and treatment options for mTOR inhibitor-associated stomatitis
MDedge Hematology and Oncology
Healthy lifestyle, tree nuts may protect against colon cancer recurrence
MDedge Hematology and Oncology
Skin cancer risk similar for liver and kidney transplant recipients
MDedge Hematology and Oncology
Fighting in a passive manner active against Clostridium difficile
MDedge Hematology and Oncology
FDA panel backs licensure for epoetin alfa biosimilar
MDedge Hematology and Oncology
VIDEO: Childhood cancer survivors living longer with fewer severe health problems
MDedge Hematology and Oncology